Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
Clinical trial NCT06514261 · SUSPENDED
Trial details
- NCT number
- NCT06514261
- Sponsor
- National Cancer Institute (NCI)
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-18
- Primary completion
- 2026-09-16
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.